Melbourne Manufacturing

Employing 400 colleagues, the Mulgrave site in Melbourne’s south east has been operational since the early 1970s but Pfizer's experience in sterile medicine manufacturing dates back 100 years. The plant is focused on the development and manufacture of high potent and cytotoxic sterile injectables which are exported to more than 60 countries around the world. Currently the site produces 30 molecules as approximately 1000 SKUs in glass vial presentations between 2mL and 100mL.